HC Wainwright & Co. Downgrades Lisata Therapeutics to Neutral

Benzinga Newsdesk www.benzinga.com Negative 87.3%

Neg 87.3% Neu 0% Pos 0%

HC Wainwright & Co. analyst Joseph Pantginis downgrades Lisata Therapeutics (NASDAQ:LSTA) from Buy to Neutral.

Comments

No comments yet. Be the first!

HC Wainwright &amp; Co. Downgrades Lisata Therapeutics to Neutral